Lebrikizumab
Clinical Indication
For treating moderate to severe atopic dermatitis in people 12 years and over
Comments
Date of classification
September 2024
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.